GLUE
Monte Rosa Therapeutics Inc.
Latest News for GLUE
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Axsome Therapeutics (AXSM), Monte Rosa Therapeutics ......
In a report released today, Brian Cheng from J.P. Morgan maintained a Buy rating on Monte Rosa Therapeutics, with a price target of $30.00. Accordi......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eli Lilly & Co (LLY – Research Report), Lantheus (LN......
In a report released today, Derek Archila from Wells Fargo maintained a Buy rating on Monte Rosa Therapeutics, with a price target of $29.00. Accor......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alto Neuroscience, Inc. (ANRO – Research Report) and......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GLUE | $18.05 | +5.4% | 870.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Monte Rosa Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW